Guardant Health Inc [GH] stock is trading at $46.98, up 3.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GH shares have gain 1.93% over the last week, with a monthly amount glided 25.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on January 23, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $60. Previously, Guggenheim upgraded its rating to Buy on June 28, 2024, and kept the price target unchanged to $36. Guggenheim initiated its recommendation with a Neutral. In a note dated November 13, 2023, Raymond James upgraded an Outperform rating on this stock but restated the target price of $27.
Guardant Health Inc [GH] stock has fluctuated between $15.81 and $50.89 over the past year. Currently, Wall Street analysts expect the stock to reach $40 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $46.98 at the most recent close of the market. An investor can expect a potential drop of -14.86% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 692.26M for the trailing twelve months, which represents a growth of 33.87%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -0.74%, Pretax Profit Margin comes in at -0.74%, and Net Profit Margin reading is -0.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -12.4 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -22.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.94 points at the first support level, and at 44.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.78, and for the 2nd resistance point, it is at 48.59.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 6.22. In addition, the Quick Ratio stands at 5.85 and the Cash Ratio stands at 3.49. Considering the valuation of this stock, the price to sales ratio is 8.38.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Jan 17 ’25 when 116.0 shares were sold. Director, Tariq Musa completed a deal on Jan 17 ’25 to buy 116.0 shares. Meanwhile, Director Tariq Musa sold 116.0 shares on Dec 18 ’24.
